Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway

• Main Authors: Feifei Li (Author), Youyang Shi (Author), Yang Zhang (Author), Xiaojuan Yang (Author), Yi Wang (Author), Kexin Jiang (Author), Ciyi Hua (Author), Chunyu Wu (Author), Chenping Sun (Author), Yuenong Qin (Author), Sheng Liu (Author)
• Format: Book
• Published: BMC, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated. Methods Here, network pharmacology and molecular d...